Compare IRON & WT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IRON | WT |
|---|---|---|
| Founded | 2017 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.6B | 3.2B |
| IPO Year | 2020 | 2011 |
| Metric | IRON | WT |
|---|---|---|
| Price | $87.40 | $21.41 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 7 |
| Target Price | ★ $126.77 | $25.71 |
| AVG Volume (30 Days) | 1.4M | ★ 2.6M |
| Earning Date | 11-05-2026 | 10-30-2026 |
| Dividend Yield | N/A | ★ 0.58% |
| EPS Growth | N/A | ★ 127.27 |
| EPS | N/A | ★ 0.46 |
| Revenue | N/A | ★ $493,753,000.00 |
| Revenue This Year | N/A | $41.58 |
| Revenue Next Year | N/A | $9.88 |
| P/E Ratio | ★ N/A | $45.15 |
| Revenue Growth | N/A | ★ 15.43 |
| 52 Week Low | $40.00 | $10.69 |
| 52 Week High | $99.50 | $25.91 |
| Indicator | IRON | WT |
|---|---|---|
| Relative Strength Index (RSI) | 65.42 | 51.03 |
| Support Level | $65.04 | $18.38 |
| Resistance Level | N/A | $21.64 |
| Average True Range (ATR) | 3.82 | 0.95 |
| MACD | 0.55 | 0.11 |
| Stochastic Oscillator | 97.64 | 87.81 |
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs), including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.
WisdomTree Inc is a financial innovator, offering a diverse suite of Exchange-traded products (ETPs), models and solutions, private market investments and digital asset-related products. It also offers digital products and services related to tokenized real world assets and stablecoins, including tokenized mutual funds (Digital Funds), as well as its institutional platform, WisdomTree Connect, and blockchain-native digital wallet, WisdomTree Prime. The company's products are distributed across various asset management industry channels, including banks, brokerage firms, registered investment advisers, institutional investors, private wealth managers and online brokers. The majority of the company's revenue is generated from advisory fees earned from ETPs.